insights_auto
Why is ARX down 11.82%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$0.48
arrow_downward
-11.82%(-0.065) 1D
Nov 2, 4:10:27 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.55
High
A$0.55
Low
A$0.48
Mkt. cap
167.76M
Avg. vol.
257.85K
Volume
752.13K
P/E ratio
47.00
52-wk high
A$0.80
52-wk low
A$0.48
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.55
High
A$0.55
Low
A$0.48
Mkt. cap
167.76M
Avg. vol.
257.85K
Volume
752.13K
P/E ratio
47.00
52-wk high
A$0.80
52-wk low
A$0.48
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
FXStreet
·
20 minutes ago
Dow Jones Industrial Average edges up as money leaves tech stocks
TradingView
·
19 minutes ago
S&P 500 ends down; Apple dips ahead of quarterly report
MarketWatch
·
32 minutes ago
The stock market has gone nowhere for the past 5 months. It’s now looking like a bargain.
Yahoo Finance
·
1 hour ago
AppLovin Is the Worst-Performing Stock in the S&P 500 This Year. Has the Market Overreacted?
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd